09-Sep-2009 -
Martek Biosciences Corporation has scored a significant victory in its long-running omega-3 patent infringement case against Swiss supplier Lonza.
29-Jul-2009 -
Daily supplements of L-carnitine during pregnancy may reverse the decline in the nutrient’s levels that occurs naturally during pregnancy, says a new study supported by Lonza.
07-Jan-2009 -
Supplements of L-carnitine may reduce the oxidation of LDL cholesterol in diabetics, indicating significant potential to boost heart health, says a new study.
30-Oct-2008 -
Supplementation with L-carnitine may restore natural losses of the nutrient that occur naturally with age, according to a new study with rats.
22-Sep-2008 -
A UK-based company says it is the world’s first to develop an algal-sourced DHA/EPA organic ingredient and is on the brink of launching in bakery, dairy and pharmaceutical products.
31-Jul-2008 -
Supplements of L-carnitine may reduce bone loss in postmenopausal women, if promising results from a rat study can be repeated in humans.
24-Jul-2008 -
Swiss supplier Lonza has turned in a healthy first half performance with its Life Science Ingredients division that includes L-carnitine, vitamin K and nicotinates performing above expectation.
22-Jul-2008 -
Swiss supplier Lonza has won approval to use its prebiotic Larch arabinogalactan ingredient in food supplements in Australia.
15-Jul-2008 -
Appointments over the last month include a new chief research and development officer at Unilever and a sales director for Niutang UK, while the Grocery Manufacturers Association is looking for a new president.
15-Jul-2008 -
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
14-Jul-2008 -
Lonza is to co-develop and manufacture Novartis' biological pipeline as part of a long term strategic partnership that has been struck between the companies.
01-Jul-2008 -
Lonza has scored a contract manufacturing agreement from Osiris Therapeutics for its investigational adult stem cell therapy is building a new facility to support future business activities in this area.